Gentherm Receives First Production Vehicle Award for its Puls.A™ Technology
NORTHVILLE, Mich., June 04, 2024 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic […]
Vision Sensing Acquisition Corp. Announces Receipt of a Deficiency Notice from Nasdaq for Failure to Timely File its 1st Quarter 2024 Form 10-Q and Announces the Filing of the Form 10-Q
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special […]
Lifeward to Present at Sidoti Virtual Investor Conference on June 12
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 04, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the […]
Weatherford Signs Memorandum of Understanding with QatarEnergy to Advance Tawteen In-Country Value Program
HOUSTON, June 04, 2024 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) announced it has signed […]
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
Information regarding the total number of voting rights andtotal number of shares of the Company as of May 31, 2024 […]
Streamline Health® To Report Fiscal First Quarter 2024 Financial Performance
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of […]
Actelis Receives New Orders to Supply Three Military Bases with Cyber-Hardened Networking Technology, Continues Momentum with U.S. Military
FREMONT, Calif., June 04, 2024 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in […]
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company […]
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology […]
Host Hotels & Resorts Announces Second Quarter 2024 Earnings Call to be Held on August 1, 2024
BETHESDA, Md., June 04, 2024 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest […]
